Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71%
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note

Gross Margin
Jiangsu Kanion Pharmaceutical Co Ltd

72.5%
Current
72%
Average
48.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.5%
=
Gross Profit
3.3B
/
Revenue
4.6B

Gross Margin Across Competitors

Country CN
Market Cap 8.3B CNY
Gross Margin
72%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 793.7B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.4T DKK
Gross Margin
85%
Country US
Market Cap 385.5B USD
Gross Margin
69%
Country US
Market Cap 260.6B USD
Gross Margin
76%
Country CH
Market Cap 213.6B CHF
Gross Margin
73%
Country UK
Market Cap 171.2B GBP
Gross Margin
82%
Country CH
Market Cap 183.5B CHF
Gross Margin
75%
Country US
Market Cap 160.4B USD
Gross Margin
71%

Profitability Report

View the profitability report to see the full profitability analysis for Jiangsu Kanion Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
72.5%
=
Gross Profit
3.3B
/
Revenue
4.6B
What is the Gross Margin of Jiangsu Kanion Pharmaceutical Co Ltd?

Based on Jiangsu Kanion Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 72.5%.